Skip to main content

Flovent HFA Side Effects

Generic name: fluticasone

Medically reviewed by Last updated on Dec 7, 2023.

Note: This document contains side effect information about fluticasone. Some dosage forms listed on this page may not apply to the brand name Flovent HFA.

Applies to fluticasone: inhalation aerosol powder, inhalation powder.

Serious side effects of Flovent HFA

Along with its needed effects, fluticasone (the active ingredient contained in Flovent HFA) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking fluticasone:

More common

Less common


Incidence not known

Get emergency help immediately if any of the following symptoms of overdose occur while taking fluticasone:

Symptoms of overdose

Other side effects of Flovent HFA

Some side effects of fluticasone may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common


Incidence not known

For Healthcare Professionals

Applies to fluticasone: compounding powder, inhalation aerosol, inhalation aerosol with adapter, inhalation powder, inhalation suspension.


The most commonly reported adverse events have included headache, upper respiratory tract infection or inflammation, throat irritation, oral candidiasis, nausea and vomiting.[Ref]


Very common (10% or more): Upper respiratory tract infection (up to 21%), nasal congestion/blockage

Common (1% to 10%): Cough, lower respiratory infection, sinusitis/sinus infection, hoarseness/dysphonia, bronchitis, pneumonia (in COPD patients), rhinitis

Rare (0.01% to 0.1%): Paradoxical bronchospasm

Frequency not reported: Epistaxis; ear, nose, throat, and tonsil signs and symptoms; ear, nose, and throat polyps

Postmarketing reports: Asthma exacerbation, wheeze[Ref]


Uncommon (0.1% to 1%): Cutaneous hypersensitivity reactions

Rare (0.01% to 0.1%): Angioedema (mainly facial and oropharyngeal), respiratory symptoms (dyspnea and/or bronchospasm)

Very rare (less than 0.01%): Anaphylactic reactions[Ref]


Very common (10% or more): Oropharyngeal candidiasis (up to 13.7%), throat irritation (up to 22%)

Common (1% to 10%): Nausea, vomiting, throat irritation, gastrointestinal discomfort and pain, viral gastrointestinal infection, toothache

Very rare (less than 0.01%): Dyspepsia

Frequency not reported: Abdominal discomfort, oral ulcerations, dental discomfort, oral erythema and rashes, month and tongue disorders

Postmarketing reports: Sore throat[Ref]


Rare (0.01% to 0.1%): Adrenal suppression

Frequency not reported: Cushing's syndrome, cushingoid features[Ref]


Rare (0.01% to 0.1%): Cataract, glaucoma

Frequency not reported: Keratitis, conjunctivitis, blepharoconjunctivitis[Ref]


Very rare (less than 0.01%): Anxiety, sleep disorders, behavioral changes including hyperactivity and irritability (predominantly in children), depression[Ref]


Common (1% to 10%): Muscle injury, musculoskeletal pain, back pain

Rare (0.01% to 0.1%): Growth retardation (pediatrics), decrease in bone mineral density

Very rare (less than 0.01%): Arthralgia

Postmarketing reports: Osteoporosis[Ref]

Nervous system

Very common (10% or more): Headache (up to 14%)

Common (1% to 10%): Malaise and fatigue

Frequency not reported: Dizziness

Postmarketing reports: Aphonia[Ref]


Common (1% to 10%): Malaise, fever

Frequency not reported: Allergic ear, nose, and throat disorders[Ref]


Common (1% to 10%): Contusions, pruritus, skin rash

Frequency not reported: Photodermatitis, acne and folliculitis

Postmarketing reports: Ecchymosis[Ref]


Rare (0.01% to 0.1%): Systemic eosinophilic conditions[Ref]


Very rare (less than 0.01%): Hyperglycemia

Frequency not reported: Fluid disturbances, weight gain, appetite disturbances[Ref]


Frequency not reported: Palpitations

Postmarketing reports: Chest tightness[Ref]

Frequently asked questions


1. Cerner Multum, Inc. "UK Summary of Product Characteristics."

2. Cerner Multum, Inc. "Australian Product Information."

3. (2016) "Product Information. Flovent Diskus (fluticasone)." GlaxoSmithKline

4. (2016) "Product Information. Flovent HFA (fluticasone)." GlaxoSmithKline

5. (2016) "Product Information. Arnuity Ellipta (fluticasone)." GlaxoSmithKline

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.